The ability to step on the wind stems from the layout of four and a half years ago
"I have reservations about the two popular views of 'Helicobacter pylori is the No. 1 carcinogenic factor' and 'Helicobacter pylori is found to be completely cured'." On the evening of January 18, Fan Daiming, an academician of the Chinese Academy of Engineering, made such a statement on the recently hyped "Helicobacter pylori concept".
At the turn of the new year, the U.S. Department of Health and Human Services included Helicobacter pylori in the new edition of the Carcinogens Report, which triggered a strong reaction in China's capital market on January 5. Ordinary people are worried about the risk of cancer, and capital chases related targets. Related stocks have soared by more than 30% in a few days.
Until now, the hot discussion of "Helicobacter pylori" has continued. Dispelling meaningless excessive panic while maintaining due vigilance is the attitude of the academic community towards Helicobacter pylori.
On January 6, Nuohui Health's product "Ghost Tube" was approved for listing, which is the first Helicobacter pylori testing product suitable for home self-testing in China, which is just to soothe the public's excessive anxiety. At the live broadcast of the product launch, Zhu Yeqing, CEO of Nuohui Health, said: Experts are welcome to express their opinions and speak freely, so that the public can establish a comprehensive and in-depth understanding of Helicobacter pylori.
In fact, the birth of a mature commercial product does not rely on concept hype.
The first relevant self-test variety in China
Before Helicobacter pylori became the "carcinogen" officially stamped by the United States, it was a bad bacterium that could cause a variety of gastrointestinal diseases and some stubborn diseases. Because of its wide range of influences, scientists studying Helicobacter pylori won the Nobel Prize in 2005.
In China, nearly 40 to 60 percent of people are infected with Helicobacter pylori, and only 1 percent eventually develop stomach cancer. However, due to the huge population base, there are still more than 70 million potential stomach cancer groups.
Zhang Kai, deputy director of the Cancer Prevention Department of the Cancer Hospital of the Chinese Academy of Medical Sciences, stressed that the bad eating habits of young people are easy to breed Helicobacter pylori, "Patients with stomach disease infected with Helicobacter pylori, once they develop atrophic gastritis, are irreversible." ”
The key to the prevention and control of Helicobacter pylori is early detection. Academician Fan Daiming clearly expressed his opposition to the concept of speculation, and at the same time stressed: When there are symptoms, it must be detected and paid attention to.
The real dilemma is that Helicobacter pylori is usually a family cluster infection, but it is inconvenient and unrealistic for the whole family to go to the hospital for testing, and many people miss the early prevention and treatment window.
As a home self-test product, the most important thing about "ghost tube" is to solve the above pain points. The Health Bureau learned that in order to achieve the goal of "convenient detection" as much as possible, the product considered a variety of factors at the beginning of the design process, and even designed the strength required for the button to facilitate the use of children and the elderly, and truly realize that the whole family can be tested at home.
Zhu Yeqing said that home testing has always been the principle of product development advocated by the company. Nuohui Health believes that the family is the most reasonable scene to complete the detection of gastrointestinal diseases, and related products must be as convenient to use as pregnancy test sticks.
Nuohui Health Hangzhou production workshop Yuyu pipe automated production line
In addition, accuracy is also a necessary quality for a reliable inspection product. "This is the first consumer self-test helicobacter pylori test product approved by the State Food and Drug Administration, and there will be no misjudgment during the self-test process." Zhu Yeqing explained that the "ghost tube" uses fecal antigen detection technology, with a specificity of 99.1%, and the clinical trial results are highly consistent with the gold standard "breath test".
So, how long does it take for a testing product that is accurate enough, convenient enough, and can be tested at home? The Health Bureau learned that Nuohui Health spent 4 and a half years developing the "Ghost Tube", and when it was approved for listing, it just caught up with the attention boom of the official US update of the "Carcinogen Report".
Products that can stand in the middle of the outlet are often both accidental and inevitable.
Home self-testing is more promising than professional inspection
As the "first share of early screening", the first product of Nuohui Health is "Chang Weiqing" for early screening of colorectal cancer. A person in the same industry told the Health Bureau: Throwing out the concept of early tumor screening is objectively a good and guide for the industry, and there are more people who know the concept of early tumor screening than before.
Although it is important to improve the public's awareness of early tumor screening, another important point is that the core of early tumor screening is self-testing for high-risk groups.
Since it is a self-test, the goal of "home self-test" is very important. However, it takes a certain amount of time for ordinary consumers to trust "home self-testing".
Interestingly, in the two tumor early screening products that Nuohui Health has listed, the "poof tube" of home self-test is higher than the more professional "Chang Weiqing" sales amount. The market is taking a stand: consumer-grade testing products are more recognized.
"Ghost Tube" is such a consumer-grade home self-test product. The Health Bureau noted that the listing review announcement of The Ghost Tube clearly states: "It belongs to the first product of the same variety in China" and "is suitable for professional business personnel to conduct Helicobacter pylori antigen testing in medical units, and also applies to consumer self-testing".
Nuohui Health explained to the Health Bureau that the launch of the ghost tube is a strategic upgrade of the company.
From tumor marker detection to Helicobacter pylori detection, the scope of testing business is expanding. In the field of tumor screening, early colorectal screening has initially matured, and Helicobacter pylori, as a class of carcinogenic factors clearly identified by WHO, can greatly advance the threshold of early screening for gastric cancer.
On the evening of January 18, Nuohui Health talked through the live broadcast of Helicobacter pylori
In China, screening for Helicobacter pylori is of practical significance. Dr. Zhang Kai believes that the infection rate of Helicobacter pylori remains high, and the public's understanding of it is insufficient. On the one hand, the early screening rate of stomach cancer in China is low; on the other hand, stomach cancer is a high incidence of cancer in China. Helicobacter pylori is a clear carcinogenic factor, and the probability of re-infection after radical treatment is less than 1%, so the benefits of early detection are very obvious.
Starting from the detection of clear carcinogenic factors is a new idea opened up by Nuohui Health for the tumor early screening industry. Previously, Zhu Yeqing said on many occasions: "Changing the life trajectory of more people can start from cultivating a small testing habit." ”
At 12:00 p.m. on January 18, the war report released by Nuohui Health showed that the sales volume of Jingdong Health's "Ghost Tube" on the first day was 10,000 pieces, breaking the single-day sales record of single products in the industry, 40% of users chose to buy for families, the sinking market transaction accounted for more than 30%, and the proportion of Jingdong health consultation and consultation exceeded 20%. Nuohui Health Tmall flagship store "Ghost Pipe" Juhuasuan first 3 hours sales of more than 1 million yuan, the whole day sales of more than 2.2 million yuan, nearly 50% of users choose to buy for the family. The layout of home self-test products has been verified by the market to be successful.
Nuohui Health has released a 2021 performance forecast: the company's revenue increased by 190.8% to 207.8% year-on-year, and the annual revenue was about 210 million yuan.
Text | David
Operational | Twenty-thirteen
Two in-depth manuscripts per day to decode medicine and health
#Nuohui Health ##幽门螺杆菌 #